Compared to anti-PD-1 treatment, immune cells in bone metastasis tumors also did not show significantly downregulation of the PMN-MDSCs or upregulation of CD8 + TILs in the combination treatment in the TME from flow cytometric results (Fig. 6B, Additional file 2: Fig. S3B). Here, CD8A is linked to bone metastasis.